This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

CBT in depression

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Cognitive methods are used to challenge the patient's negative assumptions about their relation to the world and the future. These maladaptive assumptions result in a negative perceptional bias such that every experience is perceived as undermining the patient.

Negative thought processes underpin the social withdrawal and reduced motivation and activity.

Cognitive behavioural therapy (CBT) is at least as good as standard antidepressants in treating established depression. There is evidence that CBT is effective in preventing depressive relapses for at least six years

  • in patients with recurrent major depression who have been successfully treated with antidepressant drugs, CBT was more effective than clinical management for preventing depression relapses (1). In this study there was a relapse rate of 25% in the CBT group compared with 80% in the clinical management group at 2 years. The differences in relapse rate are maintained over another 4 years with the respective relapse rates changing to 40% and 90% respectively. Note though that this study had a small sample size (45 patients) and this makes the findings more difficult to generalise

Reference:

  1. Fava GA et al. Six-year outcome of cognitive behaviour therapy for prevention of recurrent depression. Am J Psychiatry 2004;161:1872-6.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.